
STK414603
CAS No. 796115-75-8
STK414603( —— )
Catalog No. M28974 CAS No. 796115-75-8
STK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 59 | Get Quote |
![]() ![]() |
10MG | 78 | Get Quote |
![]() ![]() |
25MG | 123 | Get Quote |
![]() ![]() |
50MG | 178 | Get Quote |
![]() ![]() |
100MG | 261 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSTK414603
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.
-
DescriptionSTK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAromatase|CYP19
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number796115-75-8
-
Formula Weight252.72
-
Molecular FormulaC11H9ClN2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(Cc(cccc1)c1Cl)Nc1nccs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M Kudoh, et al. The potent and selective inhibition of estrogen production by non-steroidal aromatase inhibitor, YM511. J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):265-71.
molnova catalog



related products
-
Soyasaponin Ba
Soyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.
-
CDDO-2P-Im
CDDO-2P-Im, an analog of CDDO-Imidazolide, has a chemopreventive effect. It can reduce the size and severity of the lung tumors in the mouse lung cancer model.
-
WDR5-0102
WDR5-0102 is a compound that inhibits the WDR5-MLL1 interface (K dis = 7 μM, K d = 4 μM), selectively reducing MLL1 HMT activity without affecting the human H3K4 methyltransferase SETD7 or other HMTs, including G9a, EHMT1, SUV39H2, SETD8, PRMT3, and PRMT5.